Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $22,809.00 |
|---|---|
| Enterprise Value | $-2,292,444.00 |
| Earnings per Share | $-0.95 |
| Beta | 0.84 |
| Outstanding Shares | 7,865,000 |
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.78 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.01 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
TrivarX Limited operates as a health technology enterprise, focusing on the creation of advanced, AI-driven, and scientifically validated instruments for the detection and diagnosis of behavioral health disorders. The company's reach ext...